ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1280

Higher Body Fat Percentage in Non-Obese Late-Onset Gout Patients

Qian-Hua Li, Kui-Min Yang, Yan-Hui Xu, Xin-Yun Du, Jin-Jian Liang, Jian-Zi Lin, Ying-Qian Mo and Lie Dai, Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: gout and obesity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: There is a trend of younger gout onset related to higher obesity prevalence. BMI is limited to discriminate between fat and lean mass. Body composition (BC) analysis is an alternative tool to assess metabolic status. We aimed to investigate the characteristics of BC in early and late onset gout patients.

Methods: Consecutive gout patients who fulfilled the 2016 ACR/EULAR classification criteria were recruited between June 2017 and May 2018. BC was assessed by bioelectric impedance analysis. General obesity was classified by BMI¡Ý28 kg/m2. Central obesity was defined as a waist-hip ratio (WHR) above 0.90 for males and above 0.85 for females. The patients with gout onset before age 30 years were defined as early-onset group while the others were defined as late-onset group.

Results: Among 230 gout patients recruited, mean age was 42.3 with standard deviation 22 years. Mean serum uric acid (sUA) was 9.2 with standard deviation 2.1mg/dl and 40 (17.4%) patients presented tophi. The prevalence of general obesity and central obesity was 23.4% and 64.8%, respectively. There were 91 (39.5%) patients in early-onset group. Late-onset group (n=149) showed lower prevalence of general obesity than early-onset group [25 (16.7%) vs. 29 (31.8%), P=0.017] but higher prevalence of central obesity [99 (71.2%) vs. 50 (54.9%), P=0.016]. Among obese gout patients, late-onset group showed lower estimated glomerular filtration rate (eGFR), higher prevalence of hypertension and diabetes mellitus, WHR without significant difference in other BC indicators compared with early-onset group (Table 1). Among non-obese gout patients, late-onset group presented significantly lower level of sUA and eGFR, higher prevalence of hypertension and metabolic syndrome compared with early-onset group (P<0.05, Table 1). Non-obese late-onset gout patients exhibited higher WHR, central obesity, total fat percentage and trunk fat percentage (P<0.05, Table 1) although there were no significant difference of BMI and prevalence of overweight between the two groups.

Conclusion: There were more BMI defined obese patients in early-onset gout patients but non-obese late-onset gout patients showed more central obesity and fat percentage without difference in BMI compared with non-obese early-onset gout patients.

Acknowledgement: The present study was supported by Guangdong Natural Science Foundation, China (Grant no. 2014A030310086).


Disclosure: Q. H. Li, None; K. M. Yang, None; Y. H. Xu, None; X. Y. Du, None; J. J. Liang, None; J. Z. Lin, None; Y. Q. Mo, None; L. Dai, None.

To cite this abstract in AMA style:

Li QH, Yang KM, Xu YH, Du XY, Liang JJ, Lin JZ, Mo YQ, Dai L. Higher Body Fat Percentage in Non-Obese Late-Onset Gout Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/higher-body-fat-percentage-in-non-obese-late-onset-gout-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/higher-body-fat-percentage-in-non-obese-late-onset-gout-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology